<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03247829</url>
  </required_header>
  <id_info>
    <org_study_id>SJM-CIP-10178</org_study_id>
    <nct_id>NCT03247829</nct_id>
  </id_info>
  <brief_title>Investigation to Optimize Hemodynamic Management of Left Ventricular Assist Devices Using the CardioMEMS™</brief_title>
  <acronym>Intellect2</acronym>
  <official_title>Investigation to Optimize Hemodynamic Management of HeartMate II™ Left Ventricular Assist Device Patients Using the CardioMEMS™ Pulmonary Artery Pressure Sensor in Advanced Heart Failure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St. Jude Medical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>St. Jude Medical</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This observational post market study is intended to characterize hemodynamic-guided
      management of patients with an existing left ventricular assist device (LVAD) to protocol
      specified target ranges and its impact on functional status, quality of life, and
      readmissions
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study is an observational, single group study where all participants receive the same
      intervention. The study plans to enroll up to 100 patients at 25 US sites. All patients will
      have a HeartMate Left Ventricular Assist Device (LVAD) and a CardioMEMS device implanted as
      standard of care. After enrollment into the study, the patient will be followed until six
      month follow up completion. The objective of this clinical investigation is to understand the
      role of hemodynamic monitoring in LVAD patients and:

        -  Characterize PA pressure measurements with the CardioMEMS HF System in LVAD patients
           under different clinical and physiologic conditions

        -  Characterize the effects of PA pressure on functional status, quality of life, and
           hospital readmissions of LVAD patients

        -  Evaluate target ranges for PA pressure and assess the impact of medication and pump
           speed changes on PA pressures
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 17, 2017</start_date>
  <completion_date type="Anticipated">September 30, 2019</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Six Minute Hall Walk (6MHW) distance</measure>
    <time_frame>six months</time_frame>
    <description>Change in 6MHW distance</description>
  </primary_outcome>
  <other_outcome>
    <measure>CardioMEMS PA pressure over time</measure>
    <time_frame>six months</time_frame>
    <description>Changes in PA pressure measurement over time</description>
  </other_outcome>
  <other_outcome>
    <measure>Days PA pressure is in the pre-specified target range</measure>
    <time_frame>six months</time_frame>
    <description>Percentage of days PA pressure is in the pre-specified target range</description>
  </other_outcome>
  <other_outcome>
    <measure>PA pressure before 6MHW test to after 6MHW test</measure>
    <time_frame>six months</time_frame>
    <description>Changes in PA pressure before 6MHW test to after 6MHW test</description>
  </other_outcome>
  <other_outcome>
    <measure>CardioMEMS and HeartMate Device malfunctions</measure>
    <time_frame>six months</time_frame>
    <description>Loss of performance, such as inability to submit pressure data for CardioMEMS and/or Pump failure for LVAD</description>
  </other_outcome>
  <other_outcome>
    <measure>New York Heart Association (NYHA) classification</measure>
    <time_frame>six months</time_frame>
    <description>NYHA classification at baseline and each scheduled follow-up visit</description>
  </other_outcome>
  <other_outcome>
    <measure>EQ-5D-5L</measure>
    <time_frame>six months</time_frame>
    <description>Health related quality of life (EQ-5D-5L)</description>
  </other_outcome>
  <other_outcome>
    <measure>All-cause hospitalizations</measure>
    <time_frame>six months</time_frame>
    <description>All-cause hospitalization rate</description>
  </other_outcome>
  <other_outcome>
    <measure>Worsening heart failure events</measure>
    <time_frame>six months</time_frame>
    <description>Heart failure hospitalization rate including emergency department visits, or unscheduled clinic visits for worsening HF, volume management, and/or cardiovascular medication management</description>
  </other_outcome>
  <other_outcome>
    <measure>6MHW distance by PA pressure ranges</measure>
    <time_frame>six months</time_frame>
    <description>Change in 6MHW distance by various PA pressure ranges</description>
  </other_outcome>
  <other_outcome>
    <measure>NYHA class by PA pressure ranges</measure>
    <time_frame>six months</time_frame>
    <description>Change in NYHA class by various PA pressure ranges</description>
  </other_outcome>
  <other_outcome>
    <measure>EQ-5D-5L by PA pressure ranges</measure>
    <time_frame>six months</time_frame>
    <description>Change in EQ-5D-5L by various PA pressure ranges</description>
  </other_outcome>
  <other_outcome>
    <measure>All cause hospitalization rate by PA pressure ranges</measure>
    <time_frame>six months</time_frame>
    <description>All cause hospitalization rate by various PA pressure ranges</description>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>Patients with CardioMEMS and LVAD</arm_group_label>
    <description>Patients with CardioMEMS and LVAD, previously implanted, will receive hemodynamic management using CardioMEMS</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Hemodynamic management using CardioMEMS</intervention_name>
    <description>Using the CardioMEMS HF system, clinicians will treat to target PA pressure ranges</description>
    <arm_group_label>Patients with CardioMEMS and LVAD</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Heart Failure patients will be recruited from the clinicians practice based on the presence
        of both devices under study
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Subject has CardioMEMS HF PA Sensor and a commercially-approved HeartMate LVAD (Group
             A) OR Subject has commercially-approved HeartMate LVAD, is experiencing NYHA class III
             symptoms, and has had a previous HF hospitalization and meets FDA indications for
             CardioMEMS. The CardioMEMS sensor must be implanted within 72 hours of consent (Group
             B)

          2. Signed an informed consent form and agreed to provide access to patient and device
             data (including CardioMEMS Merlin.net data)

          3. No connectivity or transmission problems with CardioMEMS

          4. On HeartMate LVAD support for at least 3 months

          5. Age ≥ 18 years

        Exclusion Criteria:

          1. Current participation in any other clinical investigation involving a mechanical
             circulatory support device or an investigation that is likely to confound study
             results or affect study outcome

          2. Current participation in the MOMENTUM3 Clinical trial and has not completed the two
             year follow-up for that trial

          3. Inability to perform 6MHW test due to conditions other than heart failure (e.g. severe
             arthritis, orthopedic issues, amputation etc.)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Poornima Sood</last_name>
    <role>Study Director</role>
    <affiliation>Abbott</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Joanne Gilbert</last_name>
    <phone>818-493-2713</phone>
    <email>jgilbert@sjm.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Tracey Shepard</last_name>
    <phone>781-852-8283</phone>
    <email>tshepard02@sjm.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Scripps Health</name>
      <address>
        <city>La Jolla</city>
        <state>California</state>
        <zip>92037</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Janet Daniel</last_name>
      <phone>858-216-7370</phone>
      <email>daniel.janet@scripphealth.org</email>
    </contact>
    <investigator>
      <last_name>Thomas Heywood, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>USC University Hospital</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90033</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Melissa Ramos</last_name>
      <phone>323-442-7283</phone>
      <email>melissa.ramos@med.usc.edu</email>
    </contact>
    <investigator>
      <last_name>Andrew Yoon, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>San Diego Cardiac</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92123</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chris Kohlmyer</last_name>
      <phone>858-244-6886</phone>
      <email>ckohlmyer@sdcardiac.com</email>
    </contact>
    <investigator>
      <last_name>Brian Jaske, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Kentucky</name>
      <address>
        <city>Lexington</city>
        <state>Kentucky</state>
        <zip>40536</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rebekah Evans</last_name>
      <phone>859-323-8663</phone>
      <email>rebekah.evans@uky.edu</email>
    </contact>
    <investigator>
      <last_name>Maya Guglin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Nebraska Medical Center</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68105</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Taelyr Miller</last_name>
      <phone>402-559-5127</phone>
      <email>tjmiller@unmc.edu</email>
    </contact>
    <investigator>
      <last_name>Adam Burdorf, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ohio Sate University</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Neha Mali</last_name>
      <phone>614-688-5506</phone>
      <email>neha.mali@osumc.edu</email>
    </contact>
    <investigator>
      <last_name>Sitaramesh Emani, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Providence Heart and Vascular Institute</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97225</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sarah Grant</last_name>
      <phone>503-216-7370</phone>
      <email>sarah.grant@providence.org</email>
    </contact>
    <investigator>
      <last_name>Jacob Abraham, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Utah Hospital</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84132</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John Kirk</last_name>
      <phone>801-585-2340</phone>
      <email>john.kirk@hsc.utah.edu</email>
    </contact>
    <investigator>
      <last_name>Stavros Drakos, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Aurora Medical Center</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cherly Zywicki</last_name>
      <phone>414-385-2474</phone>
      <email>cheryl.zywicki@aurora.org</email>
    </contact>
    <investigator>
      <last_name>Nasir Sulemanjee, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 4, 2017</study_first_submitted>
  <study_first_submitted_qc>August 8, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">August 14, 2017</study_first_posted>
  <last_update_submitted>March 19, 2018</last_update_submitted>
  <last_update_submitted_qc>March 19, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 20, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>CardioMEMS</keyword>
  <keyword>Left Ventricular Assist Device</keyword>
  <keyword>Hemodynamic Management</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

